| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |